ArticleClinical and experimental immunology2020

Exogenous interleukin-2 can rescue in-vitro T cell activation and proliferation in patients with a novel capping protein regulator and myosin 1 linker 2 mutation.

O Shamriz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.